Search

everythinglearnresearchcommunity

for

Search:↓

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Older skin has higher cancer risk due to inflammation and stem cell issues.

FOXN1 gene variants cause low T cells and immune issues from birth.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.